2月3日 - ** 基因组医疗公司Sangamo Therapeutics SGMO.O盘前股价下跌19%至0.46美元
** SGMO 宣布以每股 0.4719 美元的价格出售 2,500 万美元的股票 (link)
** 公司在此次发售中出售了3,520万股股票和可购买1,780万股股票的预付认股权证
** 发售所得将用于营运资金和一般公司用途
** Cantor 和富国证券是此次发行的联合簿记管理人
** 五家券商中有三家给予该股 "买入 "或更高评级，两家给予 "持有 "评级；PT中值为2美元--数据由LSEG编制
** 截至上次收盘，SGMO股价年累计下跌35.2%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.